Title : Pharmacokinetic Study of Osimertinib in Cancer Patients with Mild or Moderate Hepatic Impairment.

Pub. Date : 2019 May

PMID : 30872388






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Osimertinib, an epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI), undergoes significant hepatic elimination. osimertinib epidermal growth factor receptor Homo sapiens
2 Osimertinib, an epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI), undergoes significant hepatic elimination. osimertinib epidermal growth factor receptor Homo sapiens